HOXA9 and acute myeloid leukemia: Our results showed a significant upregulation of HOTAIRM1 (P < 0.05), miR-196b (P < 0.01), HOXA9 (P < 0.01), and GFI1 (P < 0.001) in AML patients compared to healthy controls.